Skip to main content

Cardiovascular Features of Connective Tissue Diseases

 

Cardiovascular Features of Connective Tissue Diseases



Connective tissue disorders are a diverse group of inherited conditions that can affect the cardiovascular system, particularly the aorta, systemic arteries, cardiac valves, and myocardium. Some of these disorders are associated with a significant risk of aortic aneurysm, dissection, arterial rupture, or premature vascular disease.

Recognizing the characteristic cardiovascular phenotype of each disorder is important for early diagnosis, appropriate imaging surveillance, family screening, and prevention of life-threatening complications.

Marfan Syndrome

Marfan syndrome is an autosomal dominant connective tissue disorder caused primarily by pathogenic variants in the FBN1 gene, which encodes fibrillin-1.

The most important cardiovascular manifestation is aortic root dilatation, particularly involving the sinuses of Valsalva. Progressive aortic enlargement can result in aortic aneurysm, aortic regurgitation, and aortic dissection.

Mitral valve prolapse, with or without mitral regurgitation, is another important cardiac manifestation.

High-yield: Marfan syndrome = FBN1 + aortic root disease + mitral valve prolapse.

Cardiovascular features

  • Aortic root dilatation
  • Aortic aneurysm
  • Ascending aortic dissection
  • Aortic regurgitation
  • Mitral valve prolapse
  • Mitral regurgitation
  • Tricuspid valve prolapse
  • Proximal pulmonary artery dilatation

Loeys-Dietz Syndrome

Loeys-Dietz syndrome is an autosomal dominant connective tissue disorder involving abnormalities in the TGF-Ξ² signaling pathway. Important genes include TGFBR1, TGFBR2, SMAD2, SMAD3, TGFB2 and TGFB3.

The cardiovascular phenotype can be more extensive than that of classic Marfan syndrome. Aneurysms and dissections may involve multiple arterial territories, and arterial tortuosity is a characteristic finding.

Cardiovascular features

  • Aortic root dilatation
  • Aortic aneurysm
  • Aortic dissection
  • Aneurysms involving other arterial territories
  • Generalized arterial tortuosity
  • Mitral valve prolapse and regurgitation
  • Pulmonary artery dilatation
  • Congenital cardiovascular abnormalities in some patients
High-yield: Loeys-Dietz syndrome = TGF-Ξ² pathway abnormalities + widespread arterial aneurysm/dissection + arterial tortuosity.

Vascular Ehlers-Danlos Syndrome

Vascular Ehlers-Danlos syndrome (vEDS) is an important inherited vascular disorder caused predominantly by pathogenic variants in COL3A1, which encodes type III collagen. It is usually inherited in an autosomal dominant manner.

The major cardiovascular concern is arterial fragility. Patients can develop spontaneous arterial dissection, aneurysm, or rupture, sometimes without significant preceding arterial dilatation.

Cardiovascular features

  • Arterial aneurysm
  • Arterial dissection
  • Spontaneous arterial rupture
  • Thoracic arterial disease
  • Cervical arterial disease
  • Abdominal and visceral arterial complications
  • Peripheral arterial complications
  • Occasional coronary artery involvement
High-yield: Vascular EDS = COL3A1 + arterial fragility + spontaneous dissection/rupture.

Pseudoxanthoma Elasticum

Pseudoxanthoma elasticum is a hereditary disorder characterized by abnormal mineralization and fragmentation of elastic fibers. It is most commonly associated with pathogenic variants in the ABCC6 gene and is generally inherited in an autosomal recessive manner.

Cardiovascular involvement is predominantly related to arterial calcification and vascular disease rather than the classic aortic-root phenotype seen in Marfan syndrome.

Cardiovascular features

  • Peripheral arterial disease
  • Intermittent claudication
  • Premature vascular disease
  • Coronary artery disease
  • Angina
  • Arterial calcification
  • Hypertension may occur
High-yield: Pseudoxanthoma elasticum = ABCC6 + elastic fiber mineralization + premature vascular disease.

Osteogenesis Imperfecta

Osteogenesis imperfecta is primarily a disorder of type I collagen and is most commonly associated with pathogenic variants in COL1A1 or COL1A2.

Although skeletal fragility and recurrent fractures are the hallmark manifestations, cardiovascular abnormalities can also occur. These may involve the aortic root and cardiac valves.

Cardiovascular features

  • Aortic root dilatation
  • Aortic regurgitation
  • Aortic aneurysm in selected patients
  • Aortic dissection in rare cases
  • Mitral valve prolapse
  • Mitral regurgitation
High-yield: Osteogenesis imperfecta = COL1A1/COL1A2 + type I collagen abnormality + possible aortic and valvular disease.

Comparison of Major Connective Tissue Disorders

Disease Inheritance Major Cardiovascular Features Important Gene(s)
Marfan syndrome AD Aortic root dilatation, aneurysm, dissection, MVP FBN1
Loeys-Dietz syndrome AD Aortic and systemic arterial aneurysm/dissection, arterial tortuosity TGFBR1, TGFBR2, SMAD2, SMAD3, TGFB2, TGFB3
Vascular EDS AD Arterial aneurysm, dissection and rupture COL3A1
Pseudoxanthoma elasticum AR Peripheral arterial disease, coronary disease, angina and arterial calcification ABCC6
Osteogenesis imperfecta Usually AD Aortic root dilatation, aortic regurgitation, MVP and MR COL1A1, COL1A2

High-Yield Exam Pearls

  1. Marfan syndrome: Think FBN1 and aortic root dilatation.
  2. Loeys-Dietz syndrome: Think arterial tortuosity and widespread arterial aneurysms/dissections.
  3. Vascular EDS: Think COL3A1 and arterial fragility.
  4. Pseudoxanthoma elasticum: Think ABCC6 and premature vascular disease.
  5. Osteogenesis imperfecta: Think COL1A1/COL1A2 and type I collagen abnormalities.

Clinical Importance

The cardiovascular risk associated with connective tissue disease varies substantially between syndromes. Aortic root disease is particularly important in Marfan syndrome, while Loeys-Dietz syndrome may involve multiple arterial territories. Vascular EDS is characterized by marked arterial fragility and carries a risk of spontaneous arterial rupture or dissection.

Depending on the underlying diagnosis and individual phenotype, cardiovascular surveillance may include echocardiography, CT angiography, MR angiography, blood-pressure assessment, genetic testing, and family screening.

Early recognition is particularly important because cardiovascular complications may develop before severe symptoms occur. Patients with known or suspected heritable aortopathy should therefore undergo appropriate specialist assessment and individualized imaging surveillance.

Conclusion

Connective tissue diseases should be considered an important cause of inherited cardiovascular disease. Understanding the characteristic association between the syndrome, inheritance pattern, gene, and cardiovascular phenotype allows clinicians to identify high-risk patients and institute appropriate surveillance.

drmusmanjaved.com

Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...